Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2013 | 1 |
2017 | 1 |
2018 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131.
N Engl J Med. 2023.
PMID: 37256976
Clinical Trial.
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators.
Miles D, et al.
Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2.
Ann Oncol. 2021.
PMID: 34224826
Free article.
Clinical Trial.
Item in Clipboard
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group.
Martin M, et al.
Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13.
Lancet Oncol. 2017.
PMID: 29146401
Clinical Trial.
Item in Clipboard
Experience with eribulin in patients with metastatic breast cancer and associated hepatic impairment: case studies.
Acosta-Eyzaguirre D, Calvo Plaza I, Perelló Martorell A, Hernández Agudo E, García-Estévez L.
Acosta-Eyzaguirre D, et al. Among authors: calvo plaza i.
Future Oncol. 2018 Mar;14(7s):29-36. doi: 10.2217/fon-2017-0358.
Future Oncol. 2018.
PMID: 29611757
Item in Clipboard
Retrospective study assessing the role of MRI in the diagnostic procedures for early breast carcinoma: a correlation of new foci in the MRI with tumor pathological features.
Calvo-Plaza I, Ugidos L, Miró C, Quevedo P, Parras M, Márquez C, de la Cruz JJ, Suárez-Gauthier A, Pérez FJ, Herrero M, Marcos M, García-Aranda M, Hidalgo M, Estévez LG.
Calvo-Plaza I, et al.
Clin Transl Oncol. 2013 Mar;15(3):205-10. doi: 10.1007/s12094-012-0899-7. Epub 2012 Aug 8.
Clin Transl Oncol. 2013.
PMID: 22872518
Item in Clipboard
Cite
Cite